<dhhead>Management
Discussion and Analysis</dhhead>
Global
Economy
During
2024, the global economy demonstrated stability despite various economic, international
relations, and governmental challenges. Data from the World Economic Outlook (IMF) report
indicated a consistent global Gross Domestic Product (GDP) growth rate of 3.3%. Economic
expansion rates varied significantly across regions. Growth in developed nations
experienced a decline, whereas developing economies, particularly those in Asia,
maintained steady growth.
The
2024 global economic landscape was marked by persistent difficulties, including
geopolitical tensions and Red Sea disruptions. Additionally, international supply chain
complications and trade disputes between major economies continued to pose challenges.
Policy adjustments related to climate change also influenced investment patterns across
multiple sectors.
Global
inflation showed an improving trend, with the rate of 5.7% for 2024, a decrease from 6.7%
in the previous year. Developed economies are anticipated to achieve their inflation
targets sooner, averaging 2.6% in 2024. Emerging markets are expected to experience a
slower reduction in price increases.
In
response to prevailing economic conditions, leading central banks implemented notable
interest rate reductions to stimulate economic activity. December 2024 saw the most
significant coordinated series of interest rate cuts among G10 central banks since the
pandemic, with total reductions for the year amounting to 825 basis points. This period
marked a substantial easing of monetary policy not observed since 2009. (Source: World
Economic Outlook, IMF, Reuters)
Outlook
The
global economy is currently predicted to sustain a steady expansion path, with projected
growth rates of 2.8% for 2025 and 3.0% for 2026. This positive outlook is underpinned by
robust economic performance observed in the United States and significant progress within
key emerging markets.
In
the United States, growth is forecast at 1.8% in 2025 and 1.7% in 2026. This projection
accounts for anticipated adjustments in the labour market and a potential moderation in
consumer expenditure. For the Eurozone, a recovery is predicted, with growth projected to
reach 0.8% in 2025 and improve to 1.2% in 2026. This expected improvement is primarily
linked to an increase in consumer spending and a continued reduction in inflation rates.
While
the general trend indicates a deceleration in global price increases, certain regions
continue to experience stagnant conditions due to persistently high inflation levels.
Global inflation is projected to decline to 4.3% in 2025 and further to 3.6% in 2026.
Developed economies are anticipated to achieve their respective inflation targets more
rapidly than other regions. Monetary policies are expected to diverge across different
geographies, reflecting the varied economic circumstances prevalent in each.
(Source:
World Economic Outlook, IMF)
Indian
Economy
Indias
economy demonstrated a consistent pattern of expansion and stability throughout FY
2024-25, confirming its position as a major global economy showing strong growth. As per
the Second Advanced Estimate (SAE), Indias real GDP expanded by 6.5% in FY 2024-25,
moderating from the 9.2% growth reported in the First Revised Estimates for FY 2023-24.
This sustained upward trend highlights the nations solid economic foundation,
effective government policies, a dynamic services sector, and considerable domestic
spending, all contributing to a favourable view of Indias potential for long-term
economic progress.
9.7%
7.6% 9.2% 6.5% 6.2%
2022
2023 2024 2025(E) 2026(P)
Indias
economic stature continues its upward climb, with the nation now holding the position of
the worlds fourth-largest economy by nominal Gross Domestic Product (GDP) and the
third-largest when assessed by purchasing power parity (PPP). Ambitious national targets
have been set to achieve a $5 trillion economy by FY 2027-28 and a $30 trillion economy by
2047. These aims are to be accomplished through substantial infrastructure investments,
ongoing governmental reforms, and the widespread adoption of technological advancements.
Reflecting this commitment, the capital Expenditure budget for the upcoming FY 2025-26 has
increased to 11.21 lakh crores, representing 3.1% of GDP.
Integral
to this accelerated growth trajectory and increasing economic self-sufficiency have been
significant governmental reforms and considerable capital allocated towards both physical
and digital infrastructure. Government initiatives such as Make in India and
the Production-Linked Incentive (PLI) scheme have also played a crucial role.
Outlook
Indias
economy is expected to grow at a rate of 6.2% in FY 2025-26. Projections indicate that by
2030, India will likely become the worlds third-largest economy, driven by
investment in infrastructure, greater private sector capital expenditure, and the
expansion of financial services. Ongoing reforms are anticipated to support this long-term
economic advancement.
Several
factors underpin this positive outlook, including Indias favourable demographics,
increasing capital investment, proactive government schemes, and strong consumer demand.
Improved spending in rural areas, helped by moderating inflation, further reinforces this
growth trajectory. The governments focus on capital expenditure, prudent fiscal
management, and measures to boost business and consumer confidence are creating a
supportive environment for both investment and consumption.
Programmes
such as Make in India 2.0, reforms designed to improve the ease of doing business, and the
Production-Linked Incentive (PLI) scheme are intended to strengthen infrastructure,
manufacturing, and exports, positioning India as a significant player in global
manufacturing. With inflation expected to be on target by the end of this year (2025), a
more accommodating monetary policy is likely. Infrastructure development and supportive
government policies will facilitate capital formation, while rural demand will receive a
boost from initiatives like the Pradhan Mantri Garib Kalyan Anna Yojana (PMGKAY).
The
Union Budget 2025-26 presents a growth-oriented financial strategy that addresses
immediate and long-term economic needs. By increasing disposable income, prioritising
infrastructure, and promoting domestic manufacturing, the budget aims to foster sustained
economic growth while ensuring fiscal responsibility.
A
key feature is the increased income tax exemption limit of 12.75 lakh per annum, which
will enhance disposable income for middle-class households, stimulating consumer spending.
Significant investments in infrastructure, including roads and railways, will improve
connectivity and create jobs. Additionally, the budget strengthens the Production Linked
Incentive (PLI) scheme for sectors like electronics and textiles, while supporting the
Make in India initiative to establish India as a global manufacturing hub. The
transformation of India Post into a catalyst for the rural economy will further enhance
logistics and financial inclusion.
(Source:
Press Information Bureau, World Economic Outlook, IMF)
Speciality
Chemicals Industry Overview
Indias
speciality chemicals sector market value reached $64.5 billion, and is expected to reach
$92.6 billion by 2033, growing at a CAGR of 3.80%. This places India among the top global
players, ranking sixth worldwide and third in Asia, a remarkable position driven by its
cost-efficient manufacturing, skilled workforce, and expanding R&D capabilities. The
segment comprises tailored chemical products, such as agrochemicals, surfactants, polymer
additives, and construction-chemical formulations, serving diverse industries including
pharmaceuticals, agriculture, textiles, consumer goods, electronics, automotives, and
water treatment. (Source: IMARC)
An
estimated investment of 8 lakh crore ($107.38 billion) is projected for the Indian
chemicals and petrochemicals sector by 2025. Speciality chemicals constitute 20% of the
global chemicals industrys $4 trillion market.
Globally,
India holds the position of the fourth-largest producer of agrochemicals, following the
United States, Japan, and China. The country accounts for 16-18% of the worlds
production of dyestuffs and dye intermediates, with the Indian colourants industry
securing a global market share of approximately 15%. The chemicals industry in India
operates under a de-licensed framework, with exceptions for a limited number of hazardous
chemicals. Furthermore, India has historically been a global leader in generics and
biosimilars, and a major vaccine manufacturer, contributing over 50% of the global vaccine
supply.
The
development of various segments within Indias speciality chemicals market is being
propelled by a rising demand from end-user industries, notably food processing, personal
care, and home care. Furthermore, India has observed an increasing demand for a wide range
of cosmetic chemicals, healthcare products, and hygiene products that utilise speciality
chemicals, polymers, and oleo chemicals. This segment is anticipated to outperform other
areas. In response to this escalating demand from both domestic and overseas markets,
Indian speciality chemical companies are actively expanding their production capacities
and accelerating their capital expenditure plans, driven by strong growth visibility and
emerging opportunities.
The
broader Indian chemical and petrochemical industry is projected to reach $304 billion by
2025, growing at a CAGR of 9.3%. The overall Indian chemical industry is expected to grow
further with a CAGR of 11-12% by 2027. This growth trajectory is also influenced by global
supply chain dynamics.
For
instance, environmental concerns in China led to the cessation of activities for many
chemical companies in 2018, consequently increasing speciality chemical manufacturing in
the Indian market to ensure uninterrupted supply.
Indian
speciality chemical companies are actively pursuing import substitution strategies whilst
concurrently exploring export opportunities to accelerate their business expansion. This
strategic positioning is expected to see Indias market share in the global
speciality chemicals market increase to 4% by 2027 from 3%, and grow faster than China,
potentially reaching 6% by 2026 from 3-4% in FY 2021. (Source: IMARC, IBEF)
Growth
Drivers n
India s speciality chemicals sector is expected to grow at a CAGR of 11-12% by 2027,
increasing its share in the global market from 3% to 4%. This is being driven by rising
global demand and Chinas reduced capacity due to environmental restrictions.
n
Indian companies are increasing their capex in anticipation of future demand from key
sectors like paints and coatings, textiles, construction, home and personal care, and
agrochemicals.
n
The paint and coatings segment is growing due to rising urbanisation and higher housing
replacement demand, while textiles and personal care segments benefit from export growth
and changing consumer preferences.
n
Go vernment initiatives such as the proposed PLI scheme for agrochemicals and the
development of PCPIRs are expected to strengthen manufacturing and reduce dependence on
imports.
n
PCPIR regions like Dahej, Paradeep, Cuddalore, and
Vishakhapatnam
have attracted over 2.1 lakh crore ($28 billion) in investments, offering large-scale,
integrated infrastructure for speciality chemical manufacturing.
n
The push for green chemistry and sustainable production is leading to more investment in
R&D and value-added product lines, helping Indian companies move up the value chain.
Government
Initiatives n
Che micals and Petrochemicals Vision The2034: government has outlined a
long-term vision to make India a global manufacturing hub for chemicals and
petrochemicals. The strategy focuses on infrastructure, self-sufficiency, domestic value
addition, and reduced import dependence.
n
Pr oposed PLI Scheme for Agrochemicals: A Production-Linked Incentive (PLI) scheme
is being considered for the agrochemicals segment, offering output-based incentives of
10-20% and cluster-based development to create a globally competitive ecosystem.
n
P etroleum, Chemicals, and Petrochemicals
Regions
(PCPIRs): Four
PCPIRs have been developed in Dahej, Paradeep, Cuddalore-Nagapattinam, and Vishakhapatnam.
These regions have attracted investments of over 2.1 lakh crore ($28 billion), supporting
infrastructure, single-window clearance, and large-scale employment.
n
100 % FDI under Automatic Route: The Indian government permits 100% foreign direct
investment under the automatic route in the chemical sector, with the exception of certain
hazardous chemicals, making it easier for global players to enter the Indian market.
n
Rem oval of Industrial Licensing: Most chemicals, except hazardous ones, no longer
require industrial licensing, helping streamline approvals and encouraging faster project
execution.
n
Cust om Duty Rationalisation: Basic customs duties have been reduced on several raw
materials and intermediates to promote cost efficiency and support domestic manufacturing
in downstream sectors.
n
Sup port for R&D and Innovation: The government is encouraging innovation by
supporting R&D infrastructure, including fiscal support and universityindustry
linkages to improve competitiveness.
n
National Medical Devices Policy 2023: Though not directly under chemicals, this
policy benefits the speciality chemical industry by boosting demand for medical-grade
intermediates and materials used in diagnostic and therapeutic equipment.
n
Mak e in India and Ease of Doing Business: National campaigns like Make in
India continue to promote the chemical sector, while ease-of-doing-business reforms
support investment facilitation and faster clearances.
Opportunities
and Threats
Opportunities
n
Str ong export demand: Specialty chemical companies in India are accelerating their
capex plans due to rising international demand. Indias share in the global specialty
chemicals market is expected to rise from 3% to 4% by 2027.
n
China+1 strategy: Environmental restrictions and shutdowns of chemical units in
China since 2018 have shifted global buyers to India, creating opportunities to increase
global market share.
n
End-user industry growth: Growth in the speciality chemicals sector is
significantly driven by expansion across key end-user industries. The paints and coatings
segment benefits from rising urbanisation and increased replacement demand. Construction
chemicals remain underpenetrated compared to markets like China and the US. Textile
chemicals are boosted by growing exports and domestic consumption, whilst home care and
cosmetics are supported by rising income levels and heightened hygiene awareness.
n
Go vernment support through PCPIRs: Investment regions such as Dahej, Paradeep,
Cuddalore, and
Vishakhapatnam
have attracted over 2.1 lakh crore ($28 billion) in combined investments.
n
FDI inflows and investment pipeline: Between April 2000 and Sept 2024, the chemical
sector received 1.39 lakh crore ($22.8 billion) in FDI. An additional 8 lakh crore
($107.4
billion) investment is estimated in chemicals and petrochemicals by 2025.
n
Glo bal footprint expansion: Companies like Aarti Industries and UPL are generating
more than 30-40% of revenues from overseas markets, expanding Indias presence in
value-added segments.
Threats
n
Regulatory tightening: In February 2025, the government introduced Quality Control
Orders (QCOs) covering over 150 product categories to raise safety and performance
standards. This will increase compliance costs for chemical manufacturers.
n
Exp osure to raw material imports: A significant portion of input materials is
still imported, exposing manufacturers to global price volatility and supply chain risks,
especially during geopolitical disruptions or currency fluctuations.
n
Low R&D spending: Indian chemical companies invest only around 1% of their
revenue on R&D, limiting innovation and global competitiveness in high-tech segments.
n
Envir onmental and sustainability pressures: Companies are under increasing
pressure to invest in green chemistry, waste treatment, and energy-efficient processes,
adding to capex and operational costs.
n
Exp ort dependency Whilerisks: export potential is strong, dependency on
external demand makes the industry vulnerable to global recessions, tariffs, and trade
policy changes.
Company
Overview
Valiant
Organics Ltd. (referred to as Valiant or the Company) is a
well-established Indian speciality chemical manufacturing company, tracing its origins
back to Valiant Chemical Corporation in 1984 before its incorporation as a private limited
entity in 2005 and subsequent conversion to a public limited company in 2015.
Headquartered in Mumbai, Maharashtra, the Company specialises in the production and
marketing of a diverse range of speciality chemicals and pharmaceutical intermediates. It
is recognised as a significant manufacturer of compounds such as chlorophenol derivatives,
benzene derivatives, Para Nitro Aniline (PNA), Para Amino Phenol (PAP), Ortho Anisidine,
and Para Anisidine.
The
Companys operations are supported by multiple integrated manufacturing units,
strategically positioned across Western India in locations including Sarigam, Tarapur,
Vapi, Jhagadia, and Ahmedabad. These facilities benefit from their close proximity to
major ports, enabling efficient management of both raw material imports and finished
product exports. This integrated manufacturing capability facilitates optimal capacity
utilisation and contributes to competitive production.
Valiant
extensive product portfolio serves a broad spectrum of industries, including
agrochemicals, pharmaceuticals, dyes, pigments, cosmetics, rubber, polymers, and
veterinary drugs. These chemicals are produced through sophisticated process chemistries
such as Chlorination, Ammonolysis, Hydrogenation, Acetylation, Sulphonation, and
Methoxylation, ensuring a wide array of high-quality offerings.
The
Company is distinguished by its robust in-house technological capabilities, including a
state-of-the-art laboratory staffed by qualified chemists, which ensures adherence to
international quality standards and supports continuous process technology development.
Valiant Organics Ltd. has pursued strategic growth, notably through the successful
integration of entities like Abhilasha Tex-Chem Limited and Amarjyot Chemicals Limited,
thereby broadening its product basket and diversifying its chemical expertise. This
comprehensive approach, combined with an established presence in export markets across
Asia, Europe, and the USA, reinforces Valiant Organics Ltd.s position as a reliable
and evolving player in the speciality chemical industry.
Manufacturing
Capacity
Valiant
Organics Limited manufactures high-quality speciality chemicals in six integrated plants
across five locations in Gujarat and Maharashtra. As of June 2025, the Companys
total production capacity was 70,000 tonnes per annum (TPA). The facilities are carefully
constructed to accommodate various processes, as listed below:
Manufacturing
facilities |
Process |
Sarigam |
Chlorination |
Tarapur |
Ammonolysis |
Vapi |
Ammonolysis |
Jhagadia
(Units 1 & 2) |
Hydrogenation,
Methoxylation |
Ahmedabad |
Sulphonation
and Acetylation |
Revenue
Break-Up
Regional
growth (%) |
FY
2024-25 |
FY
2023-24 |
Domestic |
94% |
94% |
Exports |
6% |
6% |
Operational
Diversity
Valiant
Organics Limited is part of the Aarti Group, which comprises prominent enterprises like
Aarti Surfactants, Aarti Industries, and Aarti Drugs. The company specialised in a variety
of chemical processes, such as acetylation, hydrogenation, ammonolysis, chlorination, and
methoxylation. This comprehensive expertise enables Valiant Organics to provide
high-quality products while meeting an extensive spectrum of chemical needs.
The
Companys primary product range includes important chemicals, including Para
Chlorophenol, Ortho Chlorophenol, 2,4 Dichlorophenol, Para Nitro Aniline, Ortho Anisidine,
Para Anisidine, and Para Amino Phenol. These items constitute the foundation of the
Companys portfolio, catering to a variety of industrial demands. The company is one
of the worlds largest makers of chlorophenol derivatives, as well as a major local
producer of Para Nitro Aniline (PNA). The company is also a major producer of benzene
derivatives and one of the few commercial participants in the manufacturing of
ortho-anisidine and para-anisidine. In addition, the company was one of the first to
produce Para Amino Phenol (PAP) domestically. The Companys success is due to its
highly skilled and experienced team.
Financial
Overview
Financial
Performance FY 2024-25
(
in millions)
Particulars |
FY
2024-25 |
FY
2023-24 |
YoY
(%) |
Revenue
from Operations |
7,188 |
6,772 |
6.1% |
EBITDA |
618.09 |
423 |
46.1% |
Profit
After Tax (PAT) |
(30) |
(30) |
- |
Basic/Diluted
EPS (INR) |
ign=right
style=margin-top:3.0pt;margin-right:0cm;
margin-bottom:3.0pt;margin-left:0cm;text-align:right;mso-pagination:none;
mso-layout-grid-align:none;text-autospace:none>(1.09) |
(1.09) |
- |
Key
Financial Ratios Particulars |
FY
2024-25 |
FY
2023-24 |
YOY
(% Change) |
Explanations |
Current
ratio |
0.99 |
0.97 |
200
bps |
The
Current Ratio improved marginally from 0.97 in FY 2023-24 to 0.99 |
|
|
|
|
in
FY 2024-25, reflecting a stable liquidity position. The improvement was |
|
|
|
|
supported
by better working capital management, timely collection from |
|
|
|
|
customers,
and disciplined utilization of current assets. Additionally, the |
|
|
|
|
Company
honored its commitments by making significant payments towards |
|
|
|
|
trade
payables during the year, which, while reducing current liabilities, |
|
|
|
|
demonstrates
prudent financial discipline and stronger vendor relationships. |
Net
debt-to- |
0.31 |
0.32 |
- |
The
Net Debt-to-Equity ratio declined from 0.32 in FY 2023-24 to 0.31 in FY |
equity |
|
|
|
2024-25,
indicating a marginal reduction in leverage. The improvement was |
|
|
|
|
primarily
on account of repayment of borrowings, along with better working |
|
|
|
|
capital
management. Notably, the Company reduced outstanding trade |
|
|
|
|
payables
through higher settlements, which was funded through internal |
|
|
|
|
accruals
and operational cash flows, further strengthening the balance sheet |
|
|
|
|
position. |
Return
on |
(0.45%) |
(0.46%) |
- |
Return
on Equity remained negative at (0.45%) in FY 2024-25, broadly in line |
equity |
|
|
|
with
FY 2023-24 levels. The negative return reflects the continued net losses |
|
|
|
|
during
the year, driven by margin pressures and higher finance costs, which |
|
|
|
|
offset
the benefits of a stable equity base. |
Net
profit ratio |
(0.42%) |
(0.45%) |
3
bps |
This
indicates a marginal improvement in net profit, although the ratio |
|
|
|
|
remains
negative, suggesting the company continues to incur net losses |
|
|
|
|
primarily
due to increases in finance costs, depreciation, other expenses, and |
|
|
|
|
raw
material prices. |
Strategical
Outlook
-
Valiant Organics is working towards: n Incr easing its share in the
chemical market sales. n Inno vating by improving both supply and
processes n K eeping costs low and working more efficiently
With a strong business setup, trusted customers,
and careful planning, the company is ready to grow and take on new global opportunities.
Looking ahead, the company plans to focus on: n
T echnology and Digital Tools: Using smart to predict equipment issues, track inventory
and production in real time, and manage everything through digital platform (SAP).
n P eople and Governance:
Training future based on skills and improving rules to better handle risks.
n Financial Strength: Keeping
finances healthy, using debt wisely, and making sure profits stay steady to support both
new projects and possible business purchases.
Risk
Management
The
Companys reliance on knowledge-intensive operations may lead to adverse consequences
from a lack of innovation. Furthermore, annual risks include fluctuations in oil prices as
well as foreign exchange rates. Chinas strong presence in the chemical manufacturing
industry remains a constant danger, potentially increasing the inundation of cheaper
imports.
Environmental,
Social and Governance
The
Company is dedicated to integrating health, safety, environmental, social, and governance
principles into its business operations. Valiant Organics Limited acknowledges the
potential for sustainable growth and value creation through ethical practices and robust
governance. The Company places importance on people-centricity by aligning its
environmental, health, and safety standards with international norms. Proactive measures
are implemented for the well-being of both employees and contractual workers, fostering a
positive work environment through initiatives focused on employee satisfaction, human
rights, talent management, skills development, and engagement.
The
Company is actively involved in Corporate Social Responsibility (CSR) projects that
support communities in its operational areas, demonstrating its commitment to andemployee
welfare and community development. In addition to prioritising health and safety, the
Company endeavours delivery to create a positive environment for its workforce and align
its practices with international standards. Environmental sustainability remains a primary
focus, with efforts directed at reducing hazardous waste, conserving water, improving
energy efficiency, and optimising natural resource use to minimise its carbon footprint.
The Company has implemented Zero Liquid Discharge units across most manufacturing
facilities to ensure effective waste management. Furthermore, through a captive renewable
energy plant, the Company aims to both moderate costs and reduce its environmental impact.
The
Company values strong governance and transparency as fundamental for sustainable growth
and success. Its governance structure emphasises accountability and responsibility,
supported by policies designed to protect the interests of all stakeholders.
Internal
Control System
The
Company has established a robust internal control framework, including governance,
compliance, audit, control, and reporting aspects. These internal controls play a crucial
role in ensuring regulatory compliance, fraud prevention, financial safeguarding, and the
reliability of financial reporting. The internal audit team regularly evaluates the
effectiveness of these controls and reports its findings to management. Based on these
audits, prompt corrective actions are taken to improve the accuracy and efficiency of the
internal controls.
Cautionary
Statement
The
narrative within this Management Discussion and Analysis includes forward-looking
statements relating to, among other things, the execution of strategic plans, future
business developments, and economic performance. While these statements reflect the
Companys assessment and expectations for the future direction of its business,
numerous risks, uncertainties, and other unforeseen factors could cause actual outcomes to
differ significantly from these expectations. These factors include, but are not limited
to, general market, macroeconomic, governmental, and regulatory trends, fluctuations in
currency exchange and interest rates, competitive pressures, technological advancements,
changes in the financial standing of third parties engaged with the Company, legislative
changes, and other significant factors that could influence the Companys business
and financial results.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.